The Hematocrit Paradox -How Does Blood Doping Really Work? decrease in [Hb] and Hct [51, 55] has been reported. In contrast overtraining is accompanied by a rise of [Hb] (e. g. [13] ). Why is there no increase in the concentration of Hb as reaction to chronic exercise? Neither a lack of iron nor of proteins is likely in most athletes due to the large intake of nutrients and frequent use of dietary supplements. A small decrease in ferritin concentration at constant soluble transferrin receptor concentration [45] might result from incorporation of iron into the augmented Hb mass and from the increase of plasma volume (approximately by 15 % ). 2. Generally a correlation between [Hb] and V O 2 peak for untrained as well as endurancetrained subjects is lacking or weak in crosssectional studies (e. g. [8, 13, 24] ). Only if confounding additional eff ects of training are excluded by considering nonathletes and athletes separately an increase of 0.3 % in V O 2 peak for 1 % (relative) rise in Hct can be estimated in females [8] . Wagner [61] has theoretically deduced an even smaller change: according to
Introduction ▼
It is a widespread assumption (e. g. [22, 33] ) that blood doping augments peak oxygen uptake entirely by enhancing the oxygen transport capacity of blood through an increase of hemoglobin concentration ([Hb]) or hematocrit (Hct) value. In support for this concept are results of various studies investigating blood doping eff ects (blood infusion or erythropoietin application). These investigations show improvements of V O 2 peak apparently without increases in blood volume and at least partly reversible after isovolemic hemodilution [15, 23, 33, 34, 48] . Apparently this contrasts to a variety of observations which led to the formulation of " a paradox of hematocrit in exercise physiology " (13) [7] ). Also in Kenyan runners [Hb] decreased to values typical for lowlanders within the fi rst week after descent [4, 40] . The main cause is hemodilution by an increase of plasma volume [9, 40] . Therefore suggested improvements of performance capacity after descent during normoxia cannot be caused by a high [Hb] . In a recent review Gore et al. [26] also question the importance of [Hb] changes for increases in sea-level performance after hypoxic exposure. To clarify these puzzling diff erences it might be helpful to compare " natural blood doping " in athletic animals, to discern diff erences in oxygen transport and to analyse additional mechanisms infl uencing performance after doping.
" Natural Blood Doping " in Athletic Animals ▼ In excellent runners like horses and dogs ( V O 2 peak approximately 140 ml
resting hct values tend to be lower than in man (33 % in horses, 40 % in many dogs); during exercise hct may rise to more than 60 % by expelling stored red cells from the spleen [1, 65] ). Hsia et al. [30] suggest that this " reversible autologous blood transfusion " increases V O 2 peak by 13 -30 % in highly athletic species. In contrast the small exercise induced hct increase in man by maximally 5 % results mainly from hemoconcentration by water shift to the muscles; no more than 50 ml red cells (2 -3 % of the total volume) might be supplied to the active circulation by spleen contraction [38] . Interestingly in athletic animals with a storing spleen not only circulating cell mass but also blood volume increases during exercise [30] . If the hematocrit rises during exercise from 40 to 60 % , a blood volume increase by 25 % can be calculated considering accompanying water losses to tissues (about 10 % ). Thus, the question is justifi ed whether it makes sense to increase only the hct value for improvement of oxygen transport considering the rising viscosity. The concept of the optimal hct predicts that the maximum of oxygen delivery (cardiac output times arterial O 2 content) to the tissues is reached before the steep rise of in vitro viscosity at approximately 50 % hct [37] beyond which the increasing viscosity limits blood fl ow. In dogs and horses small erythrocytes (down to less than 40 fl ) reduce fl ow resistance in small vessels. In addition equine red cells are very fl exible [2] . Interestingly the optimal hct for dog muscle perfusion increases during exercise [25] ( • ▶ Fig. 1 ), probably by augmenting the vascular diameter; also hypervolemia causes a rise of optimal hct at least at rest [19] . One might speculate that hct levels of 60 % and higher in exhausted horses correspond to their optimal in vivo hct at maximal cardiac performance.
Blood Doping in Man and Mice -Optimal Hematocrit and Cardiac Power ▼
Because of his larger red cells optimal hct should be lower in man than in dogs and horses. Robertson et al. [43, 44] estimate from results of retransfusion experiments that it ranges somewhere between 43.3 and 54.8 % in males (resting values), corresponding values for females are 38 and 45 % . Strangely, the limits of 50 % prescribed by some sport organisations might have the eff ect that dopers even better hit the optimal hct. It is interesting to speculate why humans did not develop a large spleen with high storage capacity. Perhaps the corresponding genetic mechanisms were lost by non-running ancestors living on trees. The alternative option for running hunters to select high resting hcts is dangerous (thrombosis, high blood pressure, e. g. [56] ) and might thus have generated a negative selection pressure during evolution. Therefore it is conceivable that the hct in humans is suboptimal for exercise. This hypothesis has already been discussed some decades ago in connection with reinfusion of own blood (e. g. [43] ). Until recently the optimal hct during exercise has only been measured in dogs and under artifi cial conditions. Blood was supplied to submaximally working muscles with constant perfusion pressure from a transfusion bag, not by the heart [25] . For the fi rst time the optimal hct during exercise in the whole organism has been investigated by Schuler et al. [54] . In mice doped with Epo the value amounted to 58 % at V O 2 peak. However, this value results from at least 3 factors. In addition to the changes in hct, blood volume and the rate pressure product (an estimate of the heart power) rose, thus the eff ect of an isolated hct increase remains to be determined. At a fi rst glance a change of the heart function after Epo is surprising. One might suggest that at exhaustion the heart is working to its limit because it reaches similar maximal heart rates under diff erent conditions. However, in his review Ekblom [22] mentions that Epo causes an increase in arterial blood pressure during exercise in contrast to blood infusion. Also in Lundby ' s et al. [33] doping experiments in humans, blood pressure but not heart rate at V O 2 peak was increased after Epo: The heart delivered a markedly higher mechanical power ( + 18 % ) estimated from the rate pressure product as well as calculated from stroke volume, systolic pressure and heart rate [10] at equal cardiac output as before Epo ( • ▶ Table 1 ). The latter product seems to be an adequate measure of mechanical power, since the systolic pressure -volume area is the sum of positive and negative work of the heart and linearly correlated to its V O 2 [3] . In contrast to Epo, red cell reinfusion in women (probably without a rise in blood volume) did not increase cardiac power but improved aerobic performance [43] . Unfortunately one has to doubt how far the interesting new fi ndings on cardial eff ects of Epo [33, 54] are fully reliable in a quantitative aspect. In man mean maximal systolic pressures during exercise between 120 and 140 mmHg communicated by Lundby et al. [33] are improbably low; therefore one might speculate on a calibrating error in their experiments. In mice the maximal heart rates (160 beats per min compared to 514 beats per min at rest) and even more the rate pressure products published in ref. 54 are much too low; according to the authors this was caused by mislabelling which will be corrected (personal communication M. Gassmann).
If the cardiac eff ects are real, what might be the underlying mechanism? Possibly the heart does not work at its utmost limit without doping because of unknown reasons; interestingly plasma noradrenalin concentration doubled after Epo in humans [33] . After hemodilution following Epo application cardiac output increased markedly (concomitantly with an additional noradrenalin rise) but not suffi ciently to compensate for the reduced arterial O 2 content [33] . Perhaps stroke volume could not be further increased because of mechanical restriction of diastolic fi lling; such a possibility has been discussed recently in another context [21, 32] . Based on these results one might suggest that cardiac stimulation is an important component of Epo doping.
The optimal hct might also be increased by an elevated fraction of young fl exible red cells shortly after Epo application (e. g. [60] ). However, in a recent Epo-doping study in humans no changes were detected in erythrocyte elongation at physiological shear rates [34] . In the case of autologous blood infusion the observed eff ects depend on the time schedule of application after blood storage: while the conserved red cells age continuously, regeneration in vivo produces a lot of young erythrocytes.
Additional Eff ects of Blood Doping ▼
There remains a series of possibly also important physiological eff ects of Epo or blood transfusion. A systematic search reveals the following infl uential mechanisms. Gas transport 1. The diff usion capacity for O 2 in the lungs as well as in consuming tissues increases with rising hct (e. g. [49, 65] ) because of the enlarged red cell surface area. This might also reduce exercise-induced arterial hypoxemia [20] which is especially marked in endurance-trained subjects. 2. The rising proportion of young erythrocytes [41] after Epo application optimizes in addition to deformability various functional properties (enzyme activities, buff er capacity, low oxygen affi nity increasing capillary PO 2 , (e. g. [50] ); after terminating Epo injection, however, the properties rapidly deteriorate. 3. The amount of extracellular non-bicarbonate buff ers increases with rising Hb mass [11] .
Circulatory functions
4. An increase in red cell volume might increase the blood volume thus improving the fi lling of vessels and especially of the heart and producing ergogenic eff ects at least in untrained subjects [62] . However, this seems to be compensated by a corresponding decrease in plasma volume after Epo ( [22, 34] ; after retransfusion slightly but not signifi cantly increased blood volumes occasionally have been observed in males [14, 57] but not in females [43] . In genetically modifi ed mice, Epo causes a rise in blood volume since the plasma volume is not reduced [54] . If a volume eff ect exists, it might depend on the time lag until competition after doping (especially by blood transfusion), since the down-regulation of plasma volume by renal mechanisms needs approximately 24 h (cf. [44] ). A drawback of all cited studies is that plasma volume was not measured but calculated from red cell or transfused volume and [Hb] or hct; if the ratio whole body hct / venous hct has changed, plasma volumes are not correct [59] . 5. Epo causes constriction in renal and mesenteric resistance vessels [28] which might shift blood fl ow to other parts of the circulatory system. Also Hb infl uences the diameter of the vessels by binding or liberating NO or nitrite ( [18] ) depending on saturation (reviewed in [15] ). Over extended periods Epo facilitates growing of vessels by mobilising endothelial precursor cells in bone marrow [27] . 6. Epo protects erythrocytes against radicals (via binding of iron? [17] ). Miscellaneous eff ects 7. Epo induces a shift of muscle phenotype from fast glycolytic to slow oxidative in rats [16] . It improves force in hemodialysis patients [42] and regeneration after trauma in rat muscles [46] . 8. Epo defends the brain against hypoxia, additionally it improves mood and thus probably engagement [35] . Therefore similar eff ects as with amphetamines or other stimulants are conceivable. 9. Finally the placebo eff ect has to be taken into account [5] . Astonishingly we could fi nd only few true double-blind investigations on ergogenic eff ects of blood transfusion (e. g. [12, 14, 57, 64] , 33 subjects) and Epo (e. g. [6, 63] , 18 verum vs. 17 placebo subjects). The average rise in V O 2 peak by 7 % after Epo in these investigations was not signifi cantly lower than in most not-blinded studies. However, in a study, where only the controls were blinded, the non-blinded doped subjects reached 12 % higher V O 2 peak [58] . It is also conceivable that placebo as well as mood improvement play a more important role for the duration of performance until exhaustion since submaximal endurance is percentually much more increased by blood doping than V O 2 peak: 26 % (single-blinded) after autologous red cell transfusion [44] , 54 % (not blinded) after Epo [58] .
Conclusions ▼
Considering this diversity of eff ects it remains unclear, how much of the improvement in V O 2 peak of 5 -10 % found in most studies on blood doping can be ascribed to a single factor. In any case the augmented oxygen content of arterial blood seems not to be the sole cause for ergogenic eff ects of blood transfusion and Epo. In the apparent eff ect of hct increases, the rise of oxygen capacity of blood and at least the additional factors described under gas transport (diff usion capacity, red cell properties, buff er capacity) act together and cannot be discerned. Various circulatory functions also seem to be involved in the optimized oxygen transport. Possibly mood changes and rise of cardiac power are linked by a stimulation of the sympathetic nervous system exhausting the ultimate reserves of the organism -the classical doping mechanism. Finally, there is a probable explanation of the hematocrit paradox: for evolution survival of the fi ttest in health (low hct) is more important than survival of the fi ttest in short-lasting competitions (high hct).
Note added in proof: The authors of Ref. 54 have communicated that the heart rate at maximal oxygen uptake was 700 -800 beats per minute in mice. Insertion of these values into the regression equations added to 
